Trailing Dividend / Share
$2.40
Bristol-Myers Squibb Company Ce (CELG-RI) Dividend History
Income profile from 2020 to 2024 with payout safety and yield-on-cost trend
Dividend Yield
100.0%
Payout Ratio
N/A
Unknown
Dividend Streak
5 years
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
5 straight years of dividend increases.
Income Trend
Yield on cost is 12.8% and trend is unknown.
Dividend Scorecard
Yield & Income
Dividend Yield100.0%
Trailing DPS$2.40
FrequencyAnnual
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF Payout31.8%
FCF SafetyWell Covered
Piotroski F-Score4/9
Growth
Growth Streak5 years
3Y CAGR-48.1%
5Y CAGR8.9%
Yield on Cost (5Y)12.8%
YOC Trendunknown
Total Returns
Buyback YieldN/A
Total Shareholder YieldN/A
1Y Total Return166.9%
5Y Total Return135.4%
Div Contribution (5Y)172.4%
Estimated $10K growth (return + dividends):
5Y ago$23,54410Y ago$33,09020Y ago$33,090
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Income Growth Story
Dividend per share and yield on cost over time (4 years of payments)
Dividend Safety Story
EPS is the container — dividend is what's drawn out
Dividend Analysis
Payout Safety
Bristol-Myers Squibb Company Ce has limited earnings payout data (Unknown). When measured against free cash flow—a stricter test—the payout ratio stands at 31.8%, rated "Well Covered".
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
CELG-RI has raised its dividend for 5 consecutive years, with a 3-year CAGR of -48.1% and 5-year CAGR of 8.9%.
Income Trend & Total Return
Yield on cost (5-year basis) has reached 12.8% and is currently unknown. The 5-year total return is 135.4%, with dividends contributing 172.4% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $33,090 today.
Recent Dividend Payments
Last 4 payments · Annual
TTM Total$0.41
Avg/Payment$0.1037
Latest Change-81.0%
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| Mar 7, 2024Latest | $0.0199 | ↓ -81.0% | 36.18% | Mar 11, 2024 |
| Mar 3, 2022 | $0.1046 | ↓ -26.6% | 67.52% | Mar 7, 2022 |
| Mar 4, 2021 | $0.1425 | ↓ -3.6% | 187.46% | Mar 8, 2021 |
| Mar 18, 2020 | $0.1479 | — | 95.47% | Mar 20, 2020 |
Dividend Peer Comparison
Peer group: Large diversified branded pharma
#1 yield in peer group
Div Yield
100.0%
#1 of 5
Safety
Unknown
— payout
Streak
5Y
8.9% 5Y CAGR
Total Shareholder
—
—
Annual Dividend History
36 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.02 | — | 1 | $-4.41 | — | — | 12.8% |
| 2023 | $0.00 | -100.0% | 0 | $3.86 | — | — | — |
| 2022 | $0.10 | -26.6% | 1 | $2.95 | 3.5% | 28.21x | 67.5% |
| 2021 | $0.14 | -3.6% | 1 | $3.12 | 4.6% | 21.89x | 92.0% |
| 2020 | $0.15 | — | 1 | $-3.98 | — | — | 95.5% |
| 2019 | $0.00 | — | 0 | $2.01 | — | — | — |
| 2018 | $0.00 | — | 0 | $3.03 | — | — | — |
| 2017 | $0.00 | — | 0 | $0.61 | — | — | — |
| 2016 | $0.00 | — | 0 | $2.65 | — | — | — |
| 2015 | $0.00 | — | 0 | $0.97 | — | — | — |
See CELG-RI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELG-RI Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CELG-RI vs AGIO
See how CELG-RI stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does CELG-RI pay per share?
Bristol-Myers Squibb Company Ce (CELG-RI) pays a trailing 12-month dividend of $2.40 per share, with a current dividend yield of +100.0%. Payments are made Annual.
When is CELG-RI's next ex-dividend date?
CELG-RI's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. CELG-RI typically pays dividends Annual.
Is CELG-RI's dividend safe?
CELG-RI's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of +31.8%. The 5-year growth streak provides moderate confidence.
Is CELG-RI a Dividend Payer?
Yes, Bristol-Myers Squibb Company Ce is classified as a Dividend Payer with 5 consecutive years of dividend increases. The 5-year dividend CAGR is +8.9%, demonstrating above-inflation dividend growth.
How often does CELG-RI pay dividends?
Bristol-Myers Squibb Company Ce pays dividends Annual. The trailing 12-month total is $2.40 per share. Dividend data on this page covers 4+ years from 2020 to 2024.
How much would $10,000 invested in CELG-RI grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in CELG-RI five years ago would be worth approximately $23,544 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is CELG-RI's yield on cost for long-term holders?
CELG-RI's yield on cost — the current dividend divided by the original purchase price — is +12.8% for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +100.0% market yield, thanks to consistent dividend growth.